Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

Serological cell death biomarkers and circulating tumor cells (CTCs) have potential uses as tools for pharmacodynamic blood-based assays and their subsequent application to early clinical trials. In this study, we evaluated both the expression and clinical significance of CTCs and serological cell d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hou, Jian-Mei, Greystoke, Alastair, Lancashire, Lee, Cummings, Jeff, Ward, Tim, Board, Ruth, Amir, Eitan, Hughes, Sarah, Krebs, Matthew, Hughes, Andrew, Ranson, Malcolm, Lorigan, Paul, Dive, Caroline, Blackhall, Fiona H.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Investigative Pathology 2009
Matèries:
Regular Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2716975/
https://ncbi.nlm.nih.gov/pubmed/19628770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2009.090078
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars